This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2025 Mar;45(3):e70031.

doi: 10.1111/liv.70031.

Correction to Interferons Alpha, Beta, Gamma Each Inhibit HCV Replication at the Level of Internal Ribosome Entry Site-Mediated Translation

No authors listed

PMID: 39976329
DOI: 10.1111/liv.70031

Published Erratum

Correction to Interferons Alpha, Beta, Gamma Each Inhibit HCV Replication at the Level of Internal Ribosome Entry Site-Mediated Translation

No authors listed. Liver Int. 2025 Mar.

. 2025 Mar;45(3):e70031.

doi: 10.1111/liv.70031.

PMID: 39976329
DOI: 10.1111/liv.70031

Retraction in

RETRACTION: Interferons α, β, γ Each Inhibit Hepatitis C Virus Replication at the Level of Internal Ribosome Entry Site-Mediated Translation.
[No authors listed] [No authors listed] Liver Int. 2025 Aug;45(8):e70220. doi: 10.1111/liv.70220. Liver Int. 2025. PMID: 40660480

No abstract available

PubMed Disclaimer

Erratum for

Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S, Prabhu R, Hazari S, Bastian F, Garry R, Zou W, Haque S, Joshi V, Regenstein FG, Thung SN. Dash S, et al. Liver Int. 2005 Jun;25(3):580-94. doi: 10.1111/j.1478-3231.2005.01082.x. Liver Int. 2005. Retraction in: Liver Int. 2025 Aug;45(8):e70220. doi: 10.1111/liv.70220. PMID: 15910496 Retracted.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley